Albanell-Fernandez M, Tuset M, Vergara A, Villanueva M, et al. Biomarker-driven strategy for early discontinuation of empirical antifungal treatment in critically ill patients: the role of (1-3)-beta-D-glucan using Wako(R) test. J Antimicrob Chemother 2026;81:dkag226.
PMID: 42497386